Author

M. K. Ribi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

B. Bruncsics· 1 shared C. A. Sarkar· 1 shared C. R. Bertozzi· 1 shared I. Ibarlucea-Benitez· 1 shared J. C. Stark· 1 shared J. V. Ravetch· 1 shared M. A. Gray· 1 shared M. Lustig· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

B. Bruncsics

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BioengineeringbioRxivOct 26, 2022

Antibody-lectin chimeras for glyco-immune checkpoint blockade

J. C. Stark, M. A. Gray, S. Wisnovsky…·C. R. Bertozzi

This paper introduces antibody-lectin chimeras (AbLecs) as a new immunotherapy approach that blocks glyco-immune checkpoints, enhancing cancer immune responses and synergizing with existing checkpoint inhibitors.

DOI 10.1038/s41587-025-02884-6

experimental assaydrug response / drug discovery

𝕏 PostBluesky